Published in Exp Ther Med on April 06, 2017
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 198.59
The genome sequence of Caenorhabditis briggsae: a platform for comparative genomics. PLoS Biol (2003) 13.32
Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell (2008) 7.47
CD4 T cells: fates, functions, and faults. Blood (2008) 7.03
Immunomodulatory properties of mesenchymal stromal cells. Blood (2007) 6.97
Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation (2003) 5.07
Sjögren's syndrome. Lancet (2005) 4.81
Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood (2005) 4.10
Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells (2005) 3.36
Treatment of primary Sjögren syndrome: a systematic review. JAMA (2010) 2.37
IL-6 as a keystone cytokine in health and disease. Nat Immunol (2015) 2.14
MicroRNA in autoimmunity and autoimmune diseases. J Autoimmun (2009) 2.12
MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood. PLoS One (2010) 1.49
The geoepidemiology of Sjögren's syndrome. Autoimmun Rev (2009) 1.37
The complexity of Sjögren's syndrome: novel aspects on pathogenesis. Immunol Lett (2011) 1.35
Regulation of mature T cell responses by the Wnt signaling pathway. Ann N Y Acad Sci (2012) 1.29
Advances in microRNAs: implications for immunity and inflammatory diseases. J Cell Mol Med (2009) 1.29
Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjögren syndrome. Blood (2012) 1.27
Congenic mesenchymal stem cell therapy reverses hyperglycemia in experimental type 1 diabetes. Diabetes (2010) 1.24
Role of miR-155 in the regulation of lymphocyte immune function and disease. Immunology (2014) 1.23
Altered miR-146a expression in Sjögren's syndrome and its functional role in innate immunity. Eur J Immunol (2011) 1.22
Genome-wide DNA methylation patterns in naive CD4+ T cells from patients with primary Sjögren's syndrome. Arthritis Rheumatol (2014) 1.20
Role of the frequency of blood CD4(+) CXCR5(+) CCR6(+) T cells in autoimmunity in patients with Sjögren's syndrome. Biochem Biophys Res Commun (2012) 1.18
Cytokines in Sjogren's syndrome: potential therapeutic targets. Ann Rheum Dis (2010) 1.15
Mesenchymal stem cells as an immunomodulatory therapeutic strategy for autoimmune diseases. Autoimmun Rev (2011) 1.13
PI3K signalling in inflammation. Biochim Biophys Acta (2014) 1.12
Multi-lineage potential of human mesenchymal stem cells following clonal expansion. J Musculoskelet Neuronal Interact (2001) 1.04
The p38 mitogen-activated protein kinase signaling cascade in CD4 T cells. Arthritis Res Ther (2006) 1.03
The dual roles of inflammatory cytokines and chemokines in the regulation of autoimmune diseases and their clinical implications. J Leukoc Biol (2012) 1.00
Immunoregulation by mesenchymal stem cells: biological aspects and clinical applications. J Immunol Res (2015) 1.00
β-catenin/TCF-1 pathway in T cell development and differentiation. J Neuroimmune Pharmacol (2012) 0.97
Protein kinase inhibitors in the treatment of inflammatory and autoimmune diseases. Clin Exp Immunol (2014) 0.97
Animal models of Sjögren's syndrome. Clin Rev Allergy Immunol (2007) 0.94
The IL-2/IL-2R system: from basic science to therapeutic applications to enhance immune regulation. Immunol Res (2013) 0.94
Reversal of Sjogren's-like syndrome in non-obese diabetic mice. Ann Rheum Dis (2006) 0.94
Sjögren's syndrome: a review of aetiology, pathogenesis, diagnosis and management. Aust Dent J (2010) 0.94
The contribution of epigenetics in Sjögren's Syndrome. Front Genet (2014) 0.93
The numbers of Foxp3 + Treg cells are positively correlated with higher grade of infiltration at the salivary glands in primary Sjogren's syndrome. Lupus (2009) 0.91
The use of mesenchymal stem cells in tissue engineering: A global assessment. Organogenesis (2008) 0.91
Managing Sjögren's Syndrome and non-Sjögren Syndrome dry eye with anti-inflammatory therapy. Clin Ophthalmol (2014) 0.89
Transcriptional regulatory networks for CD4 T cell differentiation. Curr Top Microbiol Immunol (2014) 0.86
Hypomethylation and overexpression of CD70 (TNFSF7) in CD4+ T cells of patients with primary Sjögren's syndrome. J Dermatol Sci (2010) 0.86
TGFβ in T cell biology and tumor immunity: Angel or devil? Cytokine Growth Factor Rev (2014) 0.85
Mesenchymal stromal cells improve salivary function and reduce lymphocytic infiltrates in mice with Sjögren's-like disease. PLoS One (2012) 0.84
Biologic treatment in Sjögren's syndrome. Rheumatology (Oxford) (2014) 0.82
mTOR signaling, Tregs and immune modulation. Immunotherapy (2014) 0.82
Study of microRNAs (miRNAs) that are predicted to target the autoantigens Ro/SSA and La/SSB in primary Sjögren's Syndrome. Clin Exp Immunol (2015) 0.82
miR-146a and miR-155 expression in PBMCs from patients with Sjögren's syndrome. J Oral Pathol Med (2014) 0.81
miR-19b downregulates intestinal SOCS3 to reduce intestinal inflammation in Crohn's disease. Sci Rep (2015) 0.81
Immunodeficiency and immune dysregulation associated with proximal defects of T cell receptor signaling. Curr Opin Immunol (2014) 0.80
Janus kinases: an ideal target for the treatment of autoimmune diseases. J Investig Dermatol Symp Proc (2013) 0.79
Bone marrow cells are a source of undifferentiated cells to prevent Sjögren's syndrome and to preserve salivary glands function in the non-obese diabetic mice. Int J Biochem Cell Biol (2010) 0.79
Treatment of primary Sjögren syndrome. Nat Rev Rheumatol (2016) 0.79
Beyond regulatory T cells: the potential role for IL-2 to deplete T-follicular helper cells and treat autoimmune diseases. Immunotherapy (2014) 0.78
Distribution of Peripheral Lymphocyte Populations in Primary Sjögren's Syndrome Patients. J Immunol Res (2015) 0.77
Activation of MKK4 (SEK1), JNK, and c-Jun in labial salivary infiltrating T cells in patients with Sjögren's syndrome. Rheumatol Int (2006) 0.76
Upregulation of membrane-bound CD40L on CD4+ T cells in women with primary Sjögren's syndrome. Scand J Immunol (2014) 0.76
Umbilical cord mesenchymal stem cells inhibit the differentiation of circulating T follicular helper cells in patients with primary Sjögren's syndrome through the secretion of indoleamine 2,3-dioxygenase. Rheumatology (Oxford) (2014) 0.76
Local activation and systemic dysregulation of T lymphocytes in Sjögren's syndrome. Curr Pharm Biotechnol (2012) 0.76
PI3K inhibitors as potential therapeutics for autoimmune disease. Drug Discov Today (2014) 0.75